Viridian Therapeutics, Inc. (VRDN) Tops Q1 EPS by 11c

Viridian Therapeutics, Inc. (NASDAQ: VRDN) reported Q1 EPS of ($0.87), $0.11 better than the analyst estimate of ($0.98). Revenue for the quarter came in at $70 thousand versus the consensus estimate of $52.09 thousand.

For earnings history and earnings-related data on Viridian Therapeutics, Inc. (VRDN) click here.

You May Also Be Interested In

• Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• Goldman Sachs Downgrades Shurgard Self Storage SA (SHUR:BB) to Neutral